跳至主要内容
临床试验/CTRI/2023/10/058526
CTRI/2023/10/058526尚未招募不适用

" A study of clinical effects of 0.5% hyperbaric levobupivacaine for spinal Anaesthesia."

Dr B R Ambedkar medical College and hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年10月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
To study the total duration of analgesia with intrathecal 0.5% hyperbaric levobupivacaine.

研究概览

简要总结

HYPERBARIC LEVOBUPIVACAINE 0.5% IS A SAFER DRUG FOR SPINAL ANAESTHESIA , THIS STUDY IS TO OBSERVE THE CLINICAL EFFECTS OF HYPERBARIC LEVOBUPIVACAINE

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • A)All patients aged between 18 to 60 years of age posted for elective surgeries under spinal anaesthesia.
  • b) ASA grade I and II patient.

排除标准

  • patients with bleeding and coagulation disorders and local site infections are excluded.

结局指标

主要结局

To study the total duration of analgesia with intrathecal 0.5% hyperbaric levobupivacaine.

时间窗: every two hours

次要结局

  • 1)Sensory Block(a)Maximum height of block achieved)

研究者

发起方
Dr B R Ambedkar medical College and hospital
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验